With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children’s Hospital / Leonard Zon, MD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|An Engineered Nanoimmunotherapy for Treating Neuroblastoma||George Washington University / Rohan Fernandes, PhD||'A' Award Grants||2016||District of Columbia|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children’s Hospital / Alan Cantor, MD, PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma||Baylor College of Medicine / Meenakshi Hegde, MD||'A' Award Grants||2016||Texas|
|Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models||Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||New York|
|Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia||Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD||'A' Award Grants||2016||New York|
|Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations||Stanford University / Ravi Majeti, MD/PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||California|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis||Washington University / Jeffrey Magee, MD/PhD||'A' Award Grants||2016||Missouri|
|Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression||University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD||'A' Award Grants||2016||Texas|